BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Institute for Bioengineering of Catalonia
X-ORIGINAL-URL:https://ibecbarcelona.eu
X-WR-CALDESC:Events for Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220429T100000
DTEND;TZID=Europe/Madrid:20220429T120000
DTSTAMP:20260404T164927
CREATED:20220422T065109Z
LAST-MODIFIED:20220422T065109Z
UID:96589-1651226400-1651233600@ibecbarcelona.eu
SUMMARY:PhD Discussions: Sefora Conti
DESCRIPTION:Mechanical phenotyping of colorectal cancer patient derived organoids based on LGR5 expression\nSefora Conti\, Integrative cell and tissue dynamics group \nColorectal cancer (CRC) tumors are composed by heterogeneous cell populations comprising differentiated cells and a small pool of cancer stem cells (CSCs). The link between cancer cell differentiation states and their metastatic potential has been the focus of extensive investigation\, with some studies pointing to microenvironmentally defined plasticity as a mechanism indispensable for metastasis formation. Another aspect that might be determinant in tumor cells ability to successfully disseminate\, intravasate\, survive in the blood stream\, extravasate\, colonize distant organs and form secondary tumors is their mechanical phenotype. \nAdopting a bottom-up approach\, we performed a broad biophysical characterization of CRC patient derived organoids (PDOs)\, engineered to fluorescently label cells expressing LGR5\, a well-established marker for CSCs. We show that CRC cells differentiation states are associated with distinct biomechanical phenotypes\, with potential repercussions on their metastatic ability. \nAt the single cell level\, LGR5+ cells display a more elongated and polarized shape while the LGR5- cells exhibit higher roundness and a smaller asymmetry in the stress field. LGR5+ are stiffer compared to their differentiated counterparts and more prone to adopt a fast amoeboid-like migration under confinement.  At the molecular level\, cancer stemness is related to differential expression of the ERM protein family\, responsible of tethering the cell membrane to the underlying actin cortex. \nThese distinct mechanical phenotypes translate to different migratory and morphological phenotypes at a cluster level. Clusters expressing high levels of LGR5 showed a more spread and flattened shape compared to more differentiated clusters. Moreover\, LGR5 expression in clusters is negatively correlated with their migration speed and their polarization state. Hence\, clusters containing more differentiated cells migrate faster\, display higher roundness and higher polarization state. \nAt higher complexity levels\, such as interactions with endothelial cells\, LGR5 expression in CRC clusters affects their ability to adhere to an endothelial monolayer and form a gap through which they attach to the underlying collagen coating. Notably\, we found that clusters expressing more LGR5 have an advantage while attaching to the endothelium as indicated by higher attachment rate and shorter time to form a gap. \nBased on these findings relating distinct mechanical phenotypes to LGR5 expression\, we speculate that mechanical adaptability coupled with cancer plasticity may be an indispensable mechanism for cancer progression.
URL:https://ibecbarcelona.eu/event/phd-discussions-sefora-conti-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220429T100000
DTEND;TZID=Europe/Madrid:20220429T120000
DTSTAMP:20260404T164927
CREATED:20220422T065109Z
LAST-MODIFIED:20220422T065109Z
UID:96592-1651226400-1651233600@ibecbarcelona.eu
SUMMARY:PhD Discussions: Sefora Conti
DESCRIPTION:Mechanical phenotyping of colorectal cancer patient derived organoids based on LGR5 expression\nSefora Conti\, Integrative cell and tissue dynamics group \nColorectal cancer (CRC) tumors are composed by heterogeneous cell populations comprising differentiated cells and a small pool of cancer stem cells (CSCs). The link between cancer cell differentiation states and their metastatic potential has been the focus of extensive investigation\, with some studies pointing to microenvironmentally defined plasticity as a mechanism indispensable for metastasis formation. Another aspect that might be determinant in tumor cells ability to successfully disseminate\, intravasate\, survive in the blood stream\, extravasate\, colonize distant organs and form secondary tumors is their mechanical phenotype. \nAdopting a bottom-up approach\, we performed a broad biophysical characterization of CRC patient derived organoids (PDOs)\, engineered to fluorescently label cells expressing LGR5\, a well-established marker for CSCs. We show that CRC cells differentiation states are associated with distinct biomechanical phenotypes\, with potential repercussions on their metastatic ability. \nAt the single cell level\, LGR5+ cells display a more elongated and polarized shape while the LGR5- cells exhibit higher roundness and a smaller asymmetry in the stress field. LGR5+ are stiffer compared to their differentiated counterparts and more prone to adopt a fast amoeboid-like migration under confinement.  At the molecular level\, cancer stemness is related to differential expression of the ERM protein family\, responsible of tethering the cell membrane to the underlying actin cortex. \nThese distinct mechanical phenotypes translate to different migratory and morphological phenotypes at a cluster level. Clusters expressing high levels of LGR5 showed a more spread and flattened shape compared to more differentiated clusters. Moreover\, LGR5 expression in clusters is negatively correlated with their migration speed and their polarization state. Hence\, clusters containing more differentiated cells migrate faster\, display higher roundness and higher polarization state. \nAt higher complexity levels\, such as interactions with endothelial cells\, LGR5 expression in CRC clusters affects their ability to adhere to an endothelial monolayer and form a gap through which they attach to the underlying collagen coating. Notably\, we found that clusters expressing more LGR5 have an advantage while attaching to the endothelium as indicated by higher attachment rate and shorter time to form a gap. \nBased on these findings relating distinct mechanical phenotypes to LGR5 expression\, we speculate that mechanical adaptability coupled with cancer plasticity may be an indispensable mechanism for cancer progression.
URL:https://ibecbarcelona.eu/event/phd-discussions-sefora-conti-3/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220429T100000
DTEND;TZID=Europe/Madrid:20220429T120000
DTSTAMP:20260404T164927
CREATED:20220422T065109Z
LAST-MODIFIED:20220422T065109Z
UID:96593-1651226400-1651233600@ibecbarcelona.eu
SUMMARY:PhD Discussions: Sefora Conti
DESCRIPTION:Mechanical phenotyping of colorectal cancer patient derived organoids based on LGR5 expression\nSefora Conti\, Integrative cell and tissue dynamics group \nColorectal cancer (CRC) tumors are composed by heterogeneous cell populations comprising differentiated cells and a small pool of cancer stem cells (CSCs). The link between cancer cell differentiation states and their metastatic potential has been the focus of extensive investigation\, with some studies pointing to microenvironmentally defined plasticity as a mechanism indispensable for metastasis formation. Another aspect that might be determinant in tumor cells ability to successfully disseminate\, intravasate\, survive in the blood stream\, extravasate\, colonize distant organs and form secondary tumors is their mechanical phenotype. \nAdopting a bottom-up approach\, we performed a broad biophysical characterization of CRC patient derived organoids (PDOs)\, engineered to fluorescently label cells expressing LGR5\, a well-established marker for CSCs. We show that CRC cells differentiation states are associated with distinct biomechanical phenotypes\, with potential repercussions on their metastatic ability. \nAt the single cell level\, LGR5+ cells display a more elongated and polarized shape while the LGR5- cells exhibit higher roundness and a smaller asymmetry in the stress field. LGR5+ are stiffer compared to their differentiated counterparts and more prone to adopt a fast amoeboid-like migration under confinement.  At the molecular level\, cancer stemness is related to differential expression of the ERM protein family\, responsible of tethering the cell membrane to the underlying actin cortex. \nThese distinct mechanical phenotypes translate to different migratory and morphological phenotypes at a cluster level. Clusters expressing high levels of LGR5 showed a more spread and flattened shape compared to more differentiated clusters. Moreover\, LGR5 expression in clusters is negatively correlated with their migration speed and their polarization state. Hence\, clusters containing more differentiated cells migrate faster\, display higher roundness and higher polarization state. \nAt higher complexity levels\, such as interactions with endothelial cells\, LGR5 expression in CRC clusters affects their ability to adhere to an endothelial monolayer and form a gap through which they attach to the underlying collagen coating. Notably\, we found that clusters expressing more LGR5 have an advantage while attaching to the endothelium as indicated by higher attachment rate and shorter time to form a gap. \nBased on these findings relating distinct mechanical phenotypes to LGR5 expression\, we speculate that mechanical adaptability coupled with cancer plasticity may be an indispensable mechanism for cancer progression.
URL:https://ibecbarcelona.eu/event/phd-discussions-sefora-conti-3/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220427T120000
DTEND;TZID=Europe/Madrid:20220427T130000
DTSTAMP:20260404T164927
CREATED:20220503T143816Z
LAST-MODIFIED:20220503T143818Z
UID:94013-1651060800-1651064400@ibecbarcelona.eu
SUMMARY:Open BIST Seminar: Dr. Wiktor Szymanski
DESCRIPTION:Molecular basis for the use of light in medicine\n\n\n\nWiktor Szymanski\, Medical Imaging Center\, University Medical Center Groningen \n\n\n\nLight is a unique control element in chemistry and biology\, because it can be safely delivered with very high precision to modulate processes in space and time. In this educational lecture\, aimed at Master students but hopefully of interest to all academics\, I will discuss the main processes that a molecule can undergo once it has been promoted to the excited state under light irradiation. Using the Jablonski diagram as the starting point\, I will outline how these processes are or could be used in the clinic for diagnostics (optical and optoacoustic imaging) and therapy (photodynamic therapy and photopharmacology). \n\n\n\n\n\n\n\nWiktor Szymanski received his PhD degree from The Warsaw University of Technology\, Poland\, in 2008\, working under the supervision of Prof. Ryszard Ostaszewski. He spent two years working on the use of biotransformations in organic chemistry with Prof. Ben L. Feringa and Prof. Dick B. Janssen at the University of Groningen. Since 2010 he has been working on the construction of photoactive protein- peptide- and DNA-bioconjugates and photopharmacology in the Feringa Labs. In 2014\, he joined the Medical Imaging Center\, University Medical Center Groningen\, where he was appointed in 2015 as tenure track assistant professor and in 2019 as associate professor (adjunct hoogleraar).
URL:https://ibecbarcelona.eu/event/open-bist-seminar-dr-wiktor-szymanski/
LOCATION:IBEC\, floor 11\, tower i
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220427T100000
DTEND;TZID=Europe/Madrid:20220430T150000
DTSTAMP:20260404T164927
CREATED:20220503T144700Z
LAST-MODIFIED:20220503T144701Z
UID:94016-1651053600-1651330800@ibecbarcelona.eu
SUMMARY:Fira Recerca en Directe 2022
DESCRIPTION:Fira Recerca en Directe\n\n\n\n\n\n\n\nLa Fira Recerca en Directe es planteja com a un tastet de projectes de recerca que estan en curs sobre diferents disciplines amb un format de proximitat\, on es presenta l’oportunitat de parlar cara a cara amb els mateixos investigadors\, així com de realitzar petits experiments amb la instrumentació científica i part del laboratori que desplacen fins a la Fira. \n\n\n\nVa néixer el 2003 per establir un canal de comunicació on es pogués transmetre a la població el mètode científic i la recerca que es porta a terme als laboratoris de tot Catalunya. \n\n\n\nParticipa el grup de “Nanobioenginyeria” amb un stand on parlaràn sobre les nanopartícules i com viatgen pel nostre cos.
URL:https://ibecbarcelona.eu/event/fira-recerca-en-directe-2022/
LOCATION:CosmoCaixa
CATEGORIES:Outreach / Fair / Festival
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220427T000000
DTEND;TZID=Europe/Madrid:20220427T130000
DTSTAMP:20260404T164927
CREATED:20220314T110017Z
LAST-MODIFIED:20220314T110017Z
UID:90931-1651017600-1651064400@ibecbarcelona.eu
SUMMARY:Open BIST Seminar: Dr. Wiktor Szymanski
DESCRIPTION:Molecular basis for the use of light in medicine\nWiktor Szymanski\, Medical Imaging Center\, University Medical Center Groningen \nLight is a unique control element in chemistry and biology\, because it can be safely delivered with very high precision to modulate processes in space and time. In this educational lecture\, aimed at Master students but hopefully of interest to all academics\, I will discuss the main processes that a molecule can undergo once it has been promoted to the excited state under light irradiation. Using the Jablonski diagram as the starting point\, I will outline how these processes are or could be used in the clinic for diagnostics (optical and optoacoustic imaging) and therapy (photodynamic therapy and photopharmacology). \n\nWiktor Szymanski received his PhD degree from The Warsaw University of Technology\, Poland\, in 2008\, working under the supervision of Prof. Ryszard Ostaszewski. He spent two years working on the use of biotransformations in organic chemistry with Prof. Ben L. Feringa and Prof. Dick B. Janssen at the University of Groningen. Since 2010 he has been working on the construction of photoactive protein- peptide- and DNA-bioconjugates and photopharmacology in the Feringa Labs. In 2014\, he joined the Medical Imaging Center\, University Medical Center Groningen\, where he was appointed in 2015 as tenure track assistant professor and in 2019 as associate professor (adjunct hoogleraar).
URL:https://ibecbarcelona.eu/event/open-bist-seminar-dr-wiktor-szymanski-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220427T000000
DTEND;TZID=Europe/Madrid:20220427T130000
DTSTAMP:20260404T164927
CREATED:20220314T110017Z
LAST-MODIFIED:20220314T110017Z
UID:96556-1651017600-1651064400@ibecbarcelona.eu
SUMMARY:Open BIST Seminar: Dr. Wiktor Szymanski
DESCRIPTION:Molecular basis for the use of light in medicine\nWiktor Szymanski\, Medical Imaging Center\, University Medical Center Groningen \nLight is a unique control element in chemistry and biology\, because it can be safely delivered with very high precision to modulate processes in space and time. In this educational lecture\, aimed at Master students but hopefully of interest to all academics\, I will discuss the main processes that a molecule can undergo once it has been promoted to the excited state under light irradiation. Using the Jablonski diagram as the starting point\, I will outline how these processes are or could be used in the clinic for diagnostics (optical and optoacoustic imaging) and therapy (photodynamic therapy and photopharmacology). \n\nWiktor Szymanski received his PhD degree from The Warsaw University of Technology\, Poland\, in 2008\, working under the supervision of Prof. Ryszard Ostaszewski. He spent two years working on the use of biotransformations in organic chemistry with Prof. Ben L. Feringa and Prof. Dick B. Janssen at the University of Groningen. Since 2010 he has been working on the construction of photoactive protein- peptide- and DNA-bioconjugates and photopharmacology in the Feringa Labs. In 2014\, he joined the Medical Imaging Center\, University Medical Center Groningen\, where he was appointed in 2015 as tenure track assistant professor and in 2019 as associate professor (adjunct hoogleraar).
URL:https://ibecbarcelona.eu/event/open-bist-seminar-dr-wiktor-szymanski-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220427T000000
DTEND;TZID=Europe/Madrid:20220427T130000
DTSTAMP:20260404T164927
CREATED:20220314T110017Z
LAST-MODIFIED:20220314T110017Z
UID:96560-1651017600-1651064400@ibecbarcelona.eu
SUMMARY:Open BIST Seminar: Dr. Wiktor Szymanski
DESCRIPTION:Molecular basis for the use of light in medicine\nWiktor Szymanski\, Medical Imaging Center\, University Medical Center Groningen \nLight is a unique control element in chemistry and biology\, because it can be safely delivered with very high precision to modulate processes in space and time. In this educational lecture\, aimed at Master students but hopefully of interest to all academics\, I will discuss the main processes that a molecule can undergo once it has been promoted to the excited state under light irradiation. Using the Jablonski diagram as the starting point\, I will outline how these processes are or could be used in the clinic for diagnostics (optical and optoacoustic imaging) and therapy (photodynamic therapy and photopharmacology). \n\nWiktor Szymanski received his PhD degree from The Warsaw University of Technology\, Poland\, in 2008\, working under the supervision of Prof. Ryszard Ostaszewski. He spent two years working on the use of biotransformations in organic chemistry with Prof. Ben L. Feringa and Prof. Dick B. Janssen at the University of Groningen. Since 2010 he has been working on the construction of photoactive protein- peptide- and DNA-bioconjugates and photopharmacology in the Feringa Labs. In 2014\, he joined the Medical Imaging Center\, University Medical Center Groningen\, where he was appointed in 2015 as tenure track assistant professor and in 2019 as associate professor (adjunct hoogleraar).
URL:https://ibecbarcelona.eu/event/open-bist-seminar-dr-wiktor-szymanski-3/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220415T100000
DTEND;TZID=Europe/Madrid:20220415T120000
DTSTAMP:20260404T164927
CREATED:20220503T144933Z
LAST-MODIFIED:20230301T140902Z
UID:94020-1650016800-1650024000@ibecbarcelona.eu
SUMMARY:PhD Discussions: Sefora Conti
DESCRIPTION:Mechanical phenotyping of colorectal cancer patient derived organoids based on LGR5 expression\n\n\n\nSefora Conti\, Integrative cell and tissue dynamics group \n\n\n\nColorectal cancer (CRC) tumors are composed by heterogeneous cell populations comprising differentiated cells and a small pool of cancer stem cells (CSCs). The link between cancer cell differentiation states and their metastatic potential has been the focus of extensive investigation\, with some studies pointing to microenvironmentally defined plasticity as a mechanism indispensable for metastasis formation. Another aspect that might be determinant in tumor cells ability to successfully disseminate\, intravasate\, survive in the blood stream\, extravasate\, colonize distant organs and form secondary tumors is their mechanical phenotype. \n\n\n\nAdopting a bottom-up approach\, we performed a broad biophysical characterization of CRC patient derived organoids (PDOs)\, engineered to fluorescently label cells expressing LGR5\, a well-established marker for CSCs. We show that CRC cells differentiation states are associated with distinct biomechanical phenotypes\, with potential repercussions on their metastatic ability. \n\n\n\nAt the single cell level\, LGR5+ cells display a more elongated and polarized shape while the LGR5- cells exhibit higher roundness and a smaller asymmetry in the stress field. LGR5+ are stiffer compared to their differentiated counterparts and more prone to adopt a fast amoeboid-like migration under confinement.  At the molecular level\, cancer stemness is related to differential expression of the ERM protein family\, responsible of tethering the cell membrane to the underlying actin cortex. \n\n\n\nThese distinct mechanical phenotypes translate to different migratory and morphological phenotypes at a cluster level. Clusters expressing high levels of LGR5 showed a more spread and flattened shape compared to more differentiated clusters. Moreover\, LGR5 expression in clusters is negatively correlated with their migration speed and their polarization state. Hence\, clusters containing more differentiated cells migrate faster\, display higher roundness and higher polarization state. \n\n\n\nAt higher complexity levels\, such as interactions with endothelial cells\, LGR5 expression in CRC clusters affects their ability to adhere to an endothelial monolayer and form a gap through which they attach to the underlying collagen coating. Notably\, we found that clusters expressing more LGR5 have an advantage while attaching to the endothelium as indicated by higher attachment rate and shorter time to form a gap. \n\n\n\nBased on these findings relating distinct mechanical phenotypes to LGR5 expression\, we speculate that mechanical adaptability coupled with cancer plasticity may be an indispensable mechanism for cancer progression.
URL:https://ibecbarcelona.eu/event/phd-discussions-sefora-conti/
LOCATION:IBEC\, floor 11\, tower i
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220413T150000
DTEND;TZID=Europe/Madrid:20220413T170000
DTSTAMP:20260404T164928
CREATED:20220503T142713Z
LAST-MODIFIED:20220503T142714Z
UID:94009-1649862000-1649869200@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Ignasi Casanellas
DESCRIPTION:Cell-adhesive nanopatterns for musculoskeletal tissue engineering\n\n\n\nIgnasi Casanellas\, Nanobioengineering Group \n\n\n\nThis thesis defence will take place at “Sala de Graus Eduard Fontseré\, Facultat de Física\, Universitat de Barcelona” at 3PM. If you wish to follow this defence online\, you can contact Ignasi here. \n\n\n\nMore information here
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-ignasi-casanellas/
LOCATION:Sala de Graus Eduard Fontseré
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220413T150000
DTEND;TZID=Europe/Madrid:20220413T170000
DTSTAMP:20260404T164928
CREATED:20220309T132156Z
LAST-MODIFIED:20220309T132156Z
UID:96549-1649862000-1649869200@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Ignasi Casanellas
DESCRIPTION:Cell-adhesive nanopatterns for musculoskeletal tissue engineering\nIgnasi Casanellas\, Nanobioengineering Group \nThis thesis defence will take place at “Sala de Graus Eduard Fontseré\, Facultat de Física\, Universitat de Barcelona” at 3PM. If you wish to follow this defence online\, you can contact Ignasi here. \nMore information here \n 
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-ignasi-casanellas-4/
LOCATION:Satisfaction survey
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220413T150000
DTEND;TZID=Europe/Madrid:20220413T170000
DTSTAMP:20260404T164928
CREATED:20220309T132156Z
LAST-MODIFIED:20220309T132156Z
UID:96545-1649862000-1649869200@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Ignasi Casanellas
DESCRIPTION:Cell-adhesive nanopatterns for musculoskeletal tissue engineering\nIgnasi Casanellas\, Nanobioengineering Group \nThis thesis defence will take place at “Sala de Graus Eduard Fontseré\, Facultat de Física\, Universitat de Barcelona” at 3PM. If you wish to follow this defence online\, you can contact Ignasi here. \nMore information here \n 
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-ignasi-casanellas-2/
LOCATION:Molecular and cellular neurobiotechnology
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220413T150000
DTEND;TZID=Europe/Madrid:20220413T170000
DTSTAMP:20260404T164928
CREATED:20220309T132156Z
LAST-MODIFIED:20220309T132156Z
UID:96548-1649862000-1649869200@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Ignasi Casanellas
DESCRIPTION:Cell-adhesive nanopatterns for musculoskeletal tissue engineering\nIgnasi Casanellas\, Nanobioengineering Group \nThis thesis defence will take place at “Sala de Graus Eduard Fontseré\, Facultat de Física\, Universitat de Barcelona” at 3PM. If you wish to follow this defence online\, you can contact Ignasi here. \nMore information here \n 
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-ignasi-casanellas-3/
LOCATION:Home
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T110000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220503T142336Z
LAST-MODIFIED:20220503T142337Z
UID:94005-1648810800-1648818000@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Francina Mesquida Veny
DESCRIPTION:Activity-dependent mechanisms of axonal growth\n\n\n\nFrancina Mesquida Veny\, Molecular and cellular neurobiotechnology  \n\n\n\nThis thesis defence will take place at “Aula de Graus” Facultat de Biologia\, Universitat de Barcelona” at 11AM. \n\n\n\nIf anyone is interested in attending online\, you can contact Francina here
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-francina-mesquida-veny/
LOCATION:Aula de Graus\, Faculty of Biology
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T110000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220324T115911Z
LAST-MODIFIED:20220324T115911Z
UID:96570-1648810800-1648818000@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Francina Mesquida Veny
DESCRIPTION:Activity-dependent mechanisms of axonal growth\nFrancina Mesquida Veny\, Molecular and cellular neurobiotechnology  \nThis thesis defence will take place at “Aula de Graus” Facultat de Biologia\, Universitat de Barcelona” at 11AM. \nIf anyone is interested in attending online\, you can contact Francina here \n 
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-francina-mesquida-veny-4/
LOCATION:Aula de Graus\, Faculty of Biology\, Diagonal\, 643\, Barcelona\, Spain
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T110000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220324T115911Z
LAST-MODIFIED:20220324T115911Z
UID:96566-1648810800-1648818000@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Francina Mesquida Veny
DESCRIPTION:Activity-dependent mechanisms of axonal growth\nFrancina Mesquida Veny\, Molecular and cellular neurobiotechnology  \nThis thesis defence will take place at “Aula de Graus” Facultat de Biologia\, Universitat de Barcelona” at 11AM. \nIf anyone is interested in attending online\, you can contact Francina here \n 
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-francina-mesquida-veny-2/
LOCATION:Aula de Graus\, Faculty of Biology\, Diagonal\, 643\, Barcelona\, Spain
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T110000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220324T115911Z
LAST-MODIFIED:20220324T115911Z
UID:96568-1648810800-1648818000@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Francina Mesquida Veny
DESCRIPTION:Activity-dependent mechanisms of axonal growth\nFrancina Mesquida Veny\, Molecular and cellular neurobiotechnology  \nThis thesis defence will take place at “Aula de Graus” Facultat de Biologia\, Universitat de Barcelona” at 11AM. \nIf anyone is interested in attending online\, you can contact Francina here \n 
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-francina-mesquida-veny-3/
LOCATION:Aula de Graus\, Faculty of Biology\, Diagonal\, 643\, Barcelona\, Spain
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T100000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220503T142003Z
LAST-MODIFIED:20220503T142004Z
UID:94001-1648807200-1648818000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Miguel Holgado
DESCRIPTION:Technologies for highly multiplexed in-vitro diagnostic systems and organ on chips. Cases studies for COVID-19 and neurodegenerative diseases\n\n\n\nMiguel Holgado\, Centro de Tecnología Biomédica-Universidad Politécnica de Madrid and Instituto de Investigación Sanitaria del Hospital Clínico San Carlos \n\n\n\nTechnologies for biomarkers screening are of very high importance\, particularly when they are reliable\, cost effective\, easy to use for measuring multiples biomarkers in a single diagnostic KIT working with real biological samples such as serum\, saliva\, wastewater or culture medium. In this paper we report technologies for the development of a highly multiplexed kit for detecting biomarkers of COVID19 in serum\, saliva[1] and wastewater analyzing their correlation with the severity of the COVID19 and showing relevant figures about the severity (90 patients in serum)\, immunity (200 volunteers in saliva donating sample every 10 days in three months)\, and wastewater. This technology has also demonstrated for measuring particular proteins of the SARS-COV-2 in wastewater\, which results have been compared with Polymerase Chain Reaction. Recently we are using these technologies for detecting Alzheimer Disease (AD) biomarkers in serum. \n\n\n\nIn concrete\, we have achieved to detect the total tau protein at the level of 10 pg mL-1 in serum as a biomarker for early detection of the AD[2]. Other biomarkers are also under development right now. In this term\, the use of advanced in vitro diagnostic systems with organ-on-chip based technologies are of a high relevance because can be used for monitoring relevant biomarkers secreted by the cells\, tissues or biopsies in these types of bioreactors. We have recently developed microfluidic chips acting as bioreactors for neuronal circuits on a chip for biological network monitoring[3] and brain slice-on-a-chip for organotypic culture and effective fluorescence injection testing[4]. Cultured neuronal networks (CNNs) are a robust model to closely investigate neuronal circuits’ formation and monitor their structural properties evolution. Typically\, neurons are cultured in plastic plates or\, more recently\, in microfluidic platforms with potentially a wide variety of neuroscience applications. As a biological protocol\, cell culture integration with a microfluidic system provides benefits such as accurate control of cell seeding area\, culture medium renewal\, or lower exposure to contamination. In this paper it is presented a novel neuronal network on a chip device\, including a chamber\, fabricated from PDMS\, vinyl and glass connected to a microfluidic platform to perfuse the continuous flow of culture medium. \n\n\n\nAs a step forward\, we employ this technology as an alternative brain slice-on-a-chip\, integrating an injection system inside the chip to dispense a fluorescent dye for long-term monitoring. Hippocampal slices are cultured inside these chips\, observing fluorescence signals from living cells\, maintaining the cytoarchitecture of the slices. Having fluorescence images of biological samples inside the chip demonstrates the effectiveness of the staining process using the injection method avoiding leaks or biological contamination. The technology developed in this study presents a significant improvement in the local administration of reagents within a brain slice-on-a-chip system\, which could be a suitable option for organotypic cultures in a microfluidic chip acting as a highly effective bioreactor. \n\n\n\n\n\n\n\n[1] Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva\, and their corresponding ELISA correlation. Sensors & Actuators: B. Chemical 345 (2021) \n\n\n\n[2] A new optical interferometric in-vitro detection for Alzheimer´ disease diagnostic in Serum. To be published elsewhere. \n\n\n\n[3] Neural circuits on a chip for biological Network Monitoring. Biotechnology Journal 2021. https://doi.org/10.1002/biot.202000355 \n\n\n\n[4] Alternative Brain Slice-on-a-Chip for Organotypic Culture and Effective Fluorescence Injection Testing. Int. J. Mol. Sci. 2022\, 23\, 2549.
URL:https://ibecbarcelona.eu/event/ibec-seminar-miguel-holgado/
LOCATION:IBEC\, floor 11\, tower i
CATEGORIES:IBEC Seminar
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T100000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220325T100932Z
LAST-MODIFIED:20220325T100932Z
UID:96572-1648807200-1648818000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Miguel Holgado
DESCRIPTION:Technologies for highly multiplexed in-vitro diagnostic systems and organ on chips. Cases studies for COVID-19 and neurodegenerative diseases\nMiguel Holgado\, Centro de Tecnología Biomédica-Universidad Politécnica de Madrid and Instituto de Investigación Sanitaria del Hospital Clínico San Carlos \nTechnologies for biomarkers screening are of very high importance\, particularly when they are reliable\, cost effective\, easy to use for measuring multiples biomarkers in a single diagnostic KIT working with real biological samples such as serum\, saliva\, wastewater or culture medium. In this paper we report technologies for the development of a highly multiplexed kit for detecting biomarkers of COVID19 in serum\, saliva[1] and wastewater analyzing their correlation with the severity of the COVID19 and showing relevant figures about the severity (90 patients in serum)\, immunity (200 volunteers in saliva donating sample every 10 days in three months)\, and wastewater. This technology has also demonstrated for measuring particular proteins of the SARS-COV-2 in wastewater\, which results have been compared with Polymerase Chain Reaction. Recently we are using these technologies for detecting Alzheimer Disease (AD) biomarkers in serum. \nIn concrete\, we have achieved to detect the total tau protein at the level of 10 pg mL-1 in serum as a biomarker for early detection of the AD[2]. Other biomarkers are also under development right now. In this term\, the use of advanced in vitro diagnostic systems with organ-on-chip based technologies are of a high relevance because can be used for monitoring relevant biomarkers secreted by the cells\, tissues or biopsies in these types of bioreactors. We have recently developed microfluidic chips acting as bioreactors for neuronal circuits on a chip for biological network monitoring[3] and brain slice-on-a-chip for organotypic culture and effective fluorescence injection testing[4]. Cultured neuronal networks (CNNs) are a robust model to closely investigate neuronal circuits’ formation and monitor their structural properties evolution. Typically\, neurons are cultured in plastic plates or\, more recently\, in microfluidic platforms with potentially a wide variety of neuroscience applications. As a biological protocol\, cell culture integration with a microfluidic system provides benefits such as accurate control of cell seeding area\, culture medium renewal\, or lower exposure to contamination. In this paper it is presented a novel neuronal network on a chip device\, including a chamber\, fabricated from PDMS\, vinyl and glass connected to a microfluidic platform to perfuse the continuous flow of culture medium. \nAs a step forward\, we employ this technology as an alternative brain slice-on-a-chip\, integrating an injection system inside the chip to dispense a fluorescent dye for long-term monitoring. Hippocampal slices are cultured inside these chips\, observing fluorescence signals from living cells\, maintaining the cytoarchitecture of the slices. Having fluorescence images of biological samples inside the chip demonstrates the effectiveness of the staining process using the injection method avoiding leaks or biological contamination. The technology developed in this study presents a significant improvement in the local administration of reagents within a brain slice-on-a-chip system\, which could be a suitable option for organotypic cultures in a microfluidic chip acting as a highly effective bioreactor. \n\n[1] Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva\, and their corresponding ELISA correlation. Sensors & Actuators: B. Chemical 345 (2021) \n[2] A new optical interferometric in-vitro detection for Alzheimer´ disease diagnostic in Serum. To be published elsewhere. \n[3] Neural circuits on a chip for biological Network Monitoring. Biotechnology Journal 2021. https://doi.org/10.1002/biot.202000355 \n[4] Alternative Brain Slice-on-a-Chip for Organotypic Culture and Effective Fluorescence Injection Testing. Int. J. Mol. Sci. 2022\, 23\, 2549.
URL:https://ibecbarcelona.eu/event/ibec-seminar-miguel-holgado-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T100000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220325T100932Z
LAST-MODIFIED:20220325T100932Z
UID:96574-1648807200-1648818000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Miguel Holgado
DESCRIPTION:Technologies for highly multiplexed in-vitro diagnostic systems and organ on chips. Cases studies for COVID-19 and neurodegenerative diseases\nMiguel Holgado\, Centro de Tecnología Biomédica-Universidad Politécnica de Madrid and Instituto de Investigación Sanitaria del Hospital Clínico San Carlos \nTechnologies for biomarkers screening are of very high importance\, particularly when they are reliable\, cost effective\, easy to use for measuring multiples biomarkers in a single diagnostic KIT working with real biological samples such as serum\, saliva\, wastewater or culture medium. In this paper we report technologies for the development of a highly multiplexed kit for detecting biomarkers of COVID19 in serum\, saliva[1] and wastewater analyzing their correlation with the severity of the COVID19 and showing relevant figures about the severity (90 patients in serum)\, immunity (200 volunteers in saliva donating sample every 10 days in three months)\, and wastewater. This technology has also demonstrated for measuring particular proteins of the SARS-COV-2 in wastewater\, which results have been compared with Polymerase Chain Reaction. Recently we are using these technologies for detecting Alzheimer Disease (AD) biomarkers in serum. \nIn concrete\, we have achieved to detect the total tau protein at the level of 10 pg mL-1 in serum as a biomarker for early detection of the AD[2]. Other biomarkers are also under development right now. In this term\, the use of advanced in vitro diagnostic systems with organ-on-chip based technologies are of a high relevance because can be used for monitoring relevant biomarkers secreted by the cells\, tissues or biopsies in these types of bioreactors. We have recently developed microfluidic chips acting as bioreactors for neuronal circuits on a chip for biological network monitoring[3] and brain slice-on-a-chip for organotypic culture and effective fluorescence injection testing[4]. Cultured neuronal networks (CNNs) are a robust model to closely investigate neuronal circuits’ formation and monitor their structural properties evolution. Typically\, neurons are cultured in plastic plates or\, more recently\, in microfluidic platforms with potentially a wide variety of neuroscience applications. As a biological protocol\, cell culture integration with a microfluidic system provides benefits such as accurate control of cell seeding area\, culture medium renewal\, or lower exposure to contamination. In this paper it is presented a novel neuronal network on a chip device\, including a chamber\, fabricated from PDMS\, vinyl and glass connected to a microfluidic platform to perfuse the continuous flow of culture medium. \nAs a step forward\, we employ this technology as an alternative brain slice-on-a-chip\, integrating an injection system inside the chip to dispense a fluorescent dye for long-term monitoring. Hippocampal slices are cultured inside these chips\, observing fluorescence signals from living cells\, maintaining the cytoarchitecture of the slices. Having fluorescence images of biological samples inside the chip demonstrates the effectiveness of the staining process using the injection method avoiding leaks or biological contamination. The technology developed in this study presents a significant improvement in the local administration of reagents within a brain slice-on-a-chip system\, which could be a suitable option for organotypic cultures in a microfluidic chip acting as a highly effective bioreactor. \n\n[1] Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva\, and their corresponding ELISA correlation. Sensors & Actuators: B. Chemical 345 (2021) \n[2] A new optical interferometric in-vitro detection for Alzheimer´ disease diagnostic in Serum. To be published elsewhere. \n[3] Neural circuits on a chip for biological Network Monitoring. Biotechnology Journal 2021. https://doi.org/10.1002/biot.202000355 \n[4] Alternative Brain Slice-on-a-Chip for Organotypic Culture and Effective Fluorescence Injection Testing. Int. J. Mol. Sci. 2022\, 23\, 2549.
URL:https://ibecbarcelona.eu/event/ibec-seminar-miguel-holgado-3/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220401T100000
DTEND;TZID=Europe/Madrid:20220401T130000
DTSTAMP:20260404T164928
CREATED:20220325T100932Z
LAST-MODIFIED:20220325T100932Z
UID:96576-1648807200-1648818000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Miguel Holgado
DESCRIPTION:Technologies for highly multiplexed in-vitro diagnostic systems and organ on chips. Cases studies for COVID-19 and neurodegenerative diseases\nMiguel Holgado\, Centro de Tecnología Biomédica-Universidad Politécnica de Madrid and Instituto de Investigación Sanitaria del Hospital Clínico San Carlos \nTechnologies for biomarkers screening are of very high importance\, particularly when they are reliable\, cost effective\, easy to use for measuring multiples biomarkers in a single diagnostic KIT working with real biological samples such as serum\, saliva\, wastewater or culture medium. In this paper we report technologies for the development of a highly multiplexed kit for detecting biomarkers of COVID19 in serum\, saliva[1] and wastewater analyzing their correlation with the severity of the COVID19 and showing relevant figures about the severity (90 patients in serum)\, immunity (200 volunteers in saliva donating sample every 10 days in three months)\, and wastewater. This technology has also demonstrated for measuring particular proteins of the SARS-COV-2 in wastewater\, which results have been compared with Polymerase Chain Reaction. Recently we are using these technologies for detecting Alzheimer Disease (AD) biomarkers in serum. \nIn concrete\, we have achieved to detect the total tau protein at the level of 10 pg mL-1 in serum as a biomarker for early detection of the AD[2]. Other biomarkers are also under development right now. In this term\, the use of advanced in vitro diagnostic systems with organ-on-chip based technologies are of a high relevance because can be used for monitoring relevant biomarkers secreted by the cells\, tissues or biopsies in these types of bioreactors. We have recently developed microfluidic chips acting as bioreactors for neuronal circuits on a chip for biological network monitoring[3] and brain slice-on-a-chip for organotypic culture and effective fluorescence injection testing[4]. Cultured neuronal networks (CNNs) are a robust model to closely investigate neuronal circuits’ formation and monitor their structural properties evolution. Typically\, neurons are cultured in plastic plates or\, more recently\, in microfluidic platforms with potentially a wide variety of neuroscience applications. As a biological protocol\, cell culture integration with a microfluidic system provides benefits such as accurate control of cell seeding area\, culture medium renewal\, or lower exposure to contamination. In this paper it is presented a novel neuronal network on a chip device\, including a chamber\, fabricated from PDMS\, vinyl and glass connected to a microfluidic platform to perfuse the continuous flow of culture medium. \nAs a step forward\, we employ this technology as an alternative brain slice-on-a-chip\, integrating an injection system inside the chip to dispense a fluorescent dye for long-term monitoring. Hippocampal slices are cultured inside these chips\, observing fluorescence signals from living cells\, maintaining the cytoarchitecture of the slices. Having fluorescence images of biological samples inside the chip demonstrates the effectiveness of the staining process using the injection method avoiding leaks or biological contamination. The technology developed in this study presents a significant improvement in the local administration of reagents within a brain slice-on-a-chip system\, which could be a suitable option for organotypic cultures in a microfluidic chip acting as a highly effective bioreactor. \n\n[1] Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva\, and their corresponding ELISA correlation. Sensors & Actuators: B. Chemical 345 (2021) \n[2] A new optical interferometric in-vitro detection for Alzheimer´ disease diagnostic in Serum. To be published elsewhere. \n[3] Neural circuits on a chip for biological Network Monitoring. Biotechnology Journal 2021. https://doi.org/10.1002/biot.202000355 \n[4] Alternative Brain Slice-on-a-Chip for Organotypic Culture and Effective Fluorescence Injection Testing. Int. J. Mol. Sci. 2022\, 23\, 2549.
URL:https://ibecbarcelona.eu/event/ibec-seminar-miguel-holgado-3/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220325T100000
DTEND;TZID=Europe/Madrid:20220325T120000
DTSTAMP:20260404T164928
CREATED:20220503T141619Z
LAST-MODIFIED:20220503T141648Z
UID:93998-1648202400-1648209600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Alejandro Mayorca
DESCRIPTION:Mapping the structure of the extracellular matrix and engineering matrixbased disease models\n\n\n\nAlejandro Mayorca\, Biotech Research and Innovation Centre\, University of Copenhagen \n\n\n\nUnderstanding disease necessitates a precise representation of the extracellular matrix (ECM)\, a vast\, intricate structure made of ~1300 interwoven proteins and glycans supporting all organs and acting as a master cell regulator. In spite of its importance\, there are no high-resolution maps of ECM topography. I will present methods to isolate ECM from mammalian organs and generate a precise\, quantitative\, three-dimensional representation of the ECM in human organs during health and incurable conditions. Further development of these methods uses ECM scaffolds to engineer experimental models that recreate cell niches associated to advanced disease\, aiming to break down the rules of their assembly. \n\n\n\n\n\n\n\nAlejandro Mayorca is an assistant professor at the Biotech Research and Innovation Centre of Copenhagen University. His work focuses on extracellular matrix research and cancer bioengineering. He is an alumnus of the Central University of Venezuela\, obtained his PhD in medical sciences from the University of Ehime\, Japan and later became a postdoc in Janine Erler’s lab at the University of Copenhagen. He isolated and characterised the structure of the extracellular matrix in primary and metastatic tumours (Nature Medicine\, 2017)\, developed techniques for whole-body ECM mapping (Nature Protocols\, 2019) and then designed ECM-based bioreactors to model lung and liver metastasis (Advanced Healthcare Materials\, 2022). \n\n\n\nSala Baobab\, Tower I\, 11 Floor\, IBEC
URL:https://ibecbarcelona.eu/event/ibec-seminar-alejandro-mayorca/
LOCATION:IBEC\, floor 11\, Tower i
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220325T100000
DTEND;TZID=Europe/Madrid:20220325T120000
DTSTAMP:20260404T164928
CREATED:20220316T105655Z
LAST-MODIFIED:20220316T105655Z
UID:91013-1648202400-1648209600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Alejandro Mayorca
DESCRIPTION:Mapping the structure of the extracellular matrix and engineering matrixbased disease models\nAlejandro Mayorca\, Biotech Research and Innovation Centre\, University of Copenhagen \nUnderstanding disease necessitates a precise representation of the extracellular matrix (ECM)\, a vast\, intricate structure made of ~1300 interwoven proteins and glycans supporting all organs and acting as a master cell regulator. In spite of its importance\, there are no high-resolution maps of ECM topography. I will present methods to isolate ECM from mammalian organs and generate a precise\, quantitative\, three-dimensional representation of the ECM in human organs during health and incurable conditions. Further development of these methods uses ECM scaffolds to engineer experimental models that recreate cell niches associated to advanced disease\, aiming to break down the rules of their assembly. \n\nAlejandro Mayorca is an assistant professor at the Biotech Research and Innovation Centre of Copenhagen University. His work focuses on extracellular matrix research and cancer bioengineering. He is an alumnus of the Central University of Venezuela\, obtained his PhD in medical sciences from the University of Ehime\, Japan and later became a postdoc in Janine Erler’s lab at the University of Copenhagen. He isolated and characterised the structure of the extracellular matrix in primary and metastatic tumours (Nature Medicine\, 2017)\, developed techniques for whole-body ECM mapping (Nature Protocols\, 2019) and then designed ECM-based bioreactors to model lung and liver metastasis (Advanced Healthcare Materials\, 2022). \nSala Baobab\, Tower I\, 11 Floor\, IBEC
URL:https://ibecbarcelona.eu/event/ibec-seminar-alejandro-mayorca-3/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220325T100000
DTEND;TZID=Europe/Madrid:20220325T120000
DTSTAMP:20260404T164928
CREATED:20220316T105655Z
LAST-MODIFIED:20220316T105655Z
UID:91014-1648202400-1648209600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Alejandro Mayorca
DESCRIPTION:Mapping the structure of the extracellular matrix and engineering matrixbased disease models\nAlejandro Mayorca\, Biotech Research and Innovation Centre\, University of Copenhagen \nUnderstanding disease necessitates a precise representation of the extracellular matrix (ECM)\, a vast\, intricate structure made of ~1300 interwoven proteins and glycans supporting all organs and acting as a master cell regulator. In spite of its importance\, there are no high-resolution maps of ECM topography. I will present methods to isolate ECM from mammalian organs and generate a precise\, quantitative\, three-dimensional representation of the ECM in human organs during health and incurable conditions. Further development of these methods uses ECM scaffolds to engineer experimental models that recreate cell niches associated to advanced disease\, aiming to break down the rules of their assembly. \n\nAlejandro Mayorca is an assistant professor at the Biotech Research and Innovation Centre of Copenhagen University. His work focuses on extracellular matrix research and cancer bioengineering. He is an alumnus of the Central University of Venezuela\, obtained his PhD in medical sciences from the University of Ehime\, Japan and later became a postdoc in Janine Erler’s lab at the University of Copenhagen. He isolated and characterised the structure of the extracellular matrix in primary and metastatic tumours (Nature Medicine\, 2017)\, developed techniques for whole-body ECM mapping (Nature Protocols\, 2019) and then designed ECM-based bioreactors to model lung and liver metastasis (Advanced Healthcare Materials\, 2022). \nSala Baobab\, Tower I\, 11 Floor\, IBEC
URL:https://ibecbarcelona.eu/event/ibec-seminar-alejandro-mayorca-3/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220325T100000
DTEND;TZID=Europe/Madrid:20220325T120000
DTSTAMP:20260404T164928
CREATED:20220316T105655Z
LAST-MODIFIED:20220316T105655Z
UID:96562-1648202400-1648209600@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Alejandro Mayorca
DESCRIPTION:Mapping the structure of the extracellular matrix and engineering matrixbased disease models\nAlejandro Mayorca\, Biotech Research and Innovation Centre\, University of Copenhagen \nUnderstanding disease necessitates a precise representation of the extracellular matrix (ECM)\, a vast\, intricate structure made of ~1300 interwoven proteins and glycans supporting all organs and acting as a master cell regulator. In spite of its importance\, there are no high-resolution maps of ECM topography. I will present methods to isolate ECM from mammalian organs and generate a precise\, quantitative\, three-dimensional representation of the ECM in human organs during health and incurable conditions. Further development of these methods uses ECM scaffolds to engineer experimental models that recreate cell niches associated to advanced disease\, aiming to break down the rules of their assembly. \n\nAlejandro Mayorca is an assistant professor at the Biotech Research and Innovation Centre of Copenhagen University. His work focuses on extracellular matrix research and cancer bioengineering. He is an alumnus of the Central University of Venezuela\, obtained his PhD in medical sciences from the University of Ehime\, Japan and later became a postdoc in Janine Erler’s lab at the University of Copenhagen. He isolated and characterised the structure of the extracellular matrix in primary and metastatic tumours (Nature Medicine\, 2017)\, developed techniques for whole-body ECM mapping (Nature Protocols\, 2019) and then designed ECM-based bioreactors to model lung and liver metastasis (Advanced Healthcare Materials\, 2022). \nSala Baobab\, Tower I\, 11 Floor\, IBEC
URL:https://ibecbarcelona.eu/event/ibec-seminar-alejandro-mayorca-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220323T140000
DTEND;TZID=Europe/Madrid:20220323T170000
DTSTAMP:20260404T164928
CREATED:20220503T134916Z
LAST-MODIFIED:20220503T134917Z
UID:93995-1648044000-1648054800@ibecbarcelona.eu
SUMMARY:ICMS-IBEC Joint Online Symposium
DESCRIPTION:This is the 6th symposium that the two institutions are celebrating together. This Mini-Symposium will take place online\, using the Teams app\, on 23 March from 14.00 – 17.00. \n\n\n\nSpeakerTitle14.00Chair: Jan van Hest (ICMS) Samuel Sánchez (IBEC)Opening and welcomeSuccessful joint ventures 14.05Shidong Song and Richard Post (IBEC & ICMS)Partnership between:Group lead IBEC: Samuel SánchezGroup lead ICMS: Remco van der Hofstad and Jan van HestEngineering transient dynamics of artificial cells by stochastic distribution of enzymes14.30Sertan Sukas (IBEC & ICMS)Partnership between:Group lead IBEC: Josep Samitier (IBEC)Group lead ICMS: Vito Conte\, Jaap den Toonder and Regina LuttgeAdvanced flow control and quantification of forces for mechanobiology studies14.55Tania Patiño Padial (IBEC→ICMS)Tania was a member of the group of Samuel Sánchez at IBEC and is now a member of the group of Jan van Hest at ICMSBioengineering life-like nanosystems for biomedical applications15.20Break Flash talks Exchange program 15.30Robert Dassen (ICMS→IBEC)Partnership between:Group leads IBEC: Veronika Magdanz and Samuel SánchezGroup lead ICMS: Hans Wyss3D printing of organ models for in vitro testing of microrobots15.38Lisa van Slagmaat (ICMS→IBEC)Partnership between:Group lead IBEC: Josep SamitierGroup lead ICMS: Jaap den ToonderMicrofluidic herringbone device with self-assembled antibody monolayer for CTC separation15.46Floor Ummels (ICMS→IBEC)Partnership between:Group lead IBEC: Giuseppe BattagliaGroup lead ICMS: Willem MulderCrossing the blood-brain barrier15.54Lisa Pomp (ICMS→IBEC)Partnership between:Group leads IBEC: José Antonio Del Río and Karen WellsGroup lead ICMS: Vito ConteEstablishment of an in vitro blood-brain barrier model on transwells for transendothelial transport studies16.04Stan van Wetten (ICMS→IBEC)Partnership between:Group lead IBEC: Sílvia PujalsGroup lead ICMS: Arthur de JongCorrelating Light and Electron Microscopy for PLGA-PEG nanoparticle charactization16.12Laura van de Koppel (ICMS→IBEC)Partnership between:Group leads IBEC: Elisabeth Engel and Bárbara BlancoGroup lead ICMS: Patricia DankersEngineering a 3D model of lymphoma using a hydrogel for precise screening of therapeutics16.20Break 16.35Roger Riera Brillas (IBEC & ICMS)Roger was a member of the  group of Lorenzo Albertazzi at IBEC and is now a member of the group of Lorenzo Albertazzi at ICMS Live-cell uPAINT imaging of receptors17.00Closing remarks 
URL:https://ibecbarcelona.eu/event/icms-ibec-joint-online-symposium/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220323T140000
DTEND;TZID=Europe/Madrid:20220323T170000
DTSTAMP:20260404T164928
CREATED:20220310T162449Z
LAST-MODIFIED:20220310T162449Z
UID:96555-1648044000-1648054800@ibecbarcelona.eu
SUMMARY:ICMS-IBEC Joint Online Symposium
DESCRIPTION:This is the 6th symposium that the two institutions are celebrating together. This Mini-Symposium will take place online\, using the Teams app\, on 23 March from 14.00 – 17.00. \n  \n\n\n\n \nSpeaker\nTitle\n\n\n14.00\nChair: Jan van Hest (ICMS)  \nSamuel Sánchez (IBEC)\nOpening and welcome\n\n\n \nSuccessful joint ventures\n\n\n\n14.05\nShidong Song and Richard Post (IBEC & ICMS) \nPartnership between: \nGroup lead IBEC: Samuel Sánchez \nGroup lead ICMS: Remco van der Hofstad and Jan van Hest\nEngineering transient dynamics of artificial cells by stochastic distribution of enzymes\n\n\n14.30\nSertan Sukas (IBEC & ICMS) \nPartnership between: \nGroup lead IBEC: Josep Samitier (IBEC) \nGroup lead ICMS: Vito Conte\, Jaap den Toonder and Regina Luttge\nAdvanced flow control and quantification of forces for mechanobiology studies\n\n\n14.55\nTania Patiño Padial (IBEC→ICMS) \nTania was a member of the group of Samuel Sánchez at IBEC and is now a member of the group of Jan van Hest at ICMS\nBioengineering life-like nanosystems for biomedical applications\n\n\n15.20\nBreak\n\n\n\n \nFlash talks Exchange program\n\n\n\n15.30\nRobert Dassen (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: Veronika Magdanz and Samuel Sánchez \nGroup lead ICMS: Hans Wyss\n3D printing of organ models for in vitro testing of microrobots\n\n\n15.38\nLisa van Slagmaat (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Josep Samitier \nGroup lead ICMS: Jaap den Toonder\nMicrofluidic herringbone device with self-assembled antibody monolayer for CTC separation\n\n\n15.46\nFloor Ummels (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Giuseppe Battaglia \nGroup lead ICMS: Willem Mulder\nCrossing the blood-brain barrier\n\n\n15.54\nLisa Pomp (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: José Antonio Del Río and Karen Wells \nGroup lead ICMS: Vito Conte\nEstablishment of an in vitro blood-brain barrier model on transwells for transendothelial transport studies\n\n\n16.04\nStan van Wetten (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Sílvia Pujals \nGroup lead ICMS: Arthur de Jong\nCorrelating Light and Electron Microscopy for PLGA-PEG nanoparticle charactization\n\n\n16.12\nLaura van de Koppel (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: Elisabeth Engel and Bárbara Blanco \nGroup lead ICMS: Patricia Dankers\nEngineering a 3D model of lymphoma using a hydrogel for precise screening of therapeutics\n\n\n16.20\nBreak \n\n\n\n16.35\nRoger Riera Brillas (IBEC & ICMS) \nRoger was a member of the  group of Lorenzo Albertazzi at IBEC and is now a member of the group of Lorenzo Albertazzi at ICMS\n Live-cell uPAINT imaging of receptors\n\n\n17.00\nClosing remarks
URL:https://ibecbarcelona.eu/event/icms-ibec-joint-online-symposium-3/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220323T140000
DTEND;TZID=Europe/Madrid:20220323T170000
DTSTAMP:20260404T164928
CREATED:20220310T162449Z
LAST-MODIFIED:20220310T162449Z
UID:90903-1648044000-1648054800@ibecbarcelona.eu
SUMMARY:ICMS-IBEC Joint Online Symposium
DESCRIPTION:This is the 6th symposium that the two institutions are celebrating together. This Mini-Symposium will take place online\, using the Teams app\, on 23 March from 14.00 – 17.00. \n  \n\n\n\n \nSpeaker\nTitle\n\n\n14.00\nChair: Jan van Hest (ICMS)  \nSamuel Sánchez (IBEC)\nOpening and welcome\n\n\n \nSuccessful joint ventures\n\n\n\n14.05\nShidong Song and Richard Post (IBEC & ICMS) \nPartnership between: \nGroup lead IBEC: Samuel Sánchez \nGroup lead ICMS: Remco van der Hofstad and Jan van Hest\nEngineering transient dynamics of artificial cells by stochastic distribution of enzymes\n\n\n14.30\nSertan Sukas (IBEC & ICMS) \nPartnership between: \nGroup lead IBEC: Josep Samitier (IBEC) \nGroup lead ICMS: Vito Conte\, Jaap den Toonder and Regina Luttge\nAdvanced flow control and quantification of forces for mechanobiology studies\n\n\n14.55\nTania Patiño Padial (IBEC→ICMS) \nTania was a member of the group of Samuel Sánchez at IBEC and is now a member of the group of Jan van Hest at ICMS\nBioengineering life-like nanosystems for biomedical applications\n\n\n15.20\nBreak\n\n\n\n \nFlash talks Exchange program\n\n\n\n15.30\nRobert Dassen (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: Veronika Magdanz and Samuel Sánchez \nGroup lead ICMS: Hans Wyss\n3D printing of organ models for in vitro testing of microrobots\n\n\n15.38\nLisa van Slagmaat (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Josep Samitier \nGroup lead ICMS: Jaap den Toonder\nMicrofluidic herringbone device with self-assembled antibody monolayer for CTC separation\n\n\n15.46\nFloor Ummels (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Giuseppe Battaglia \nGroup lead ICMS: Willem Mulder\nCrossing the blood-brain barrier\n\n\n15.54\nLisa Pomp (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: José Antonio Del Río and Karen Wells \nGroup lead ICMS: Vito Conte\nEstablishment of an in vitro blood-brain barrier model on transwells for transendothelial transport studies\n\n\n16.04\nStan van Wetten (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Sílvia Pujals \nGroup lead ICMS: Arthur de Jong\nCorrelating Light and Electron Microscopy for PLGA-PEG nanoparticle charactization\n\n\n16.12\nLaura van de Koppel (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: Elisabeth Engel and Bárbara Blanco \nGroup lead ICMS: Patricia Dankers\nEngineering a 3D model of lymphoma using a hydrogel for precise screening of therapeutics\n\n\n16.20\nBreak \n\n\n\n16.35\nRoger Riera Brillas (IBEC & ICMS) \nRoger was a member of the  group of Lorenzo Albertazzi at IBEC and is now a member of the group of Lorenzo Albertazzi at ICMS\n Live-cell uPAINT imaging of receptors\n\n\n17.00\nClosing remarks
URL:https://ibecbarcelona.eu/event/icms-ibec-joint-online-symposium-2/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220323T140000
DTEND;TZID=Europe/Madrid:20220323T170000
DTSTAMP:20260404T164928
CREATED:20220310T162449Z
LAST-MODIFIED:20220310T162449Z
UID:96553-1648044000-1648054800@ibecbarcelona.eu
SUMMARY:ICMS-IBEC Joint Online Symposium
DESCRIPTION:This is the 6th symposium that the two institutions are celebrating together. This Mini-Symposium will take place online\, using the Teams app\, on 23 March from 14.00 – 17.00. \n  \n\n\n\n \nSpeaker\nTitle\n\n\n14.00\nChair: Jan van Hest (ICMS)  \nSamuel Sánchez (IBEC)\nOpening and welcome\n\n\n \nSuccessful joint ventures\n\n\n\n14.05\nShidong Song and Richard Post (IBEC & ICMS) \nPartnership between: \nGroup lead IBEC: Samuel Sánchez \nGroup lead ICMS: Remco van der Hofstad and Jan van Hest\nEngineering transient dynamics of artificial cells by stochastic distribution of enzymes\n\n\n14.30\nSertan Sukas (IBEC & ICMS) \nPartnership between: \nGroup lead IBEC: Josep Samitier (IBEC) \nGroup lead ICMS: Vito Conte\, Jaap den Toonder and Regina Luttge\nAdvanced flow control and quantification of forces for mechanobiology studies\n\n\n14.55\nTania Patiño Padial (IBEC→ICMS) \nTania was a member of the group of Samuel Sánchez at IBEC and is now a member of the group of Jan van Hest at ICMS\nBioengineering life-like nanosystems for biomedical applications\n\n\n15.20\nBreak\n\n\n\n \nFlash talks Exchange program\n\n\n\n15.30\nRobert Dassen (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: Veronika Magdanz and Samuel Sánchez \nGroup lead ICMS: Hans Wyss\n3D printing of organ models for in vitro testing of microrobots\n\n\n15.38\nLisa van Slagmaat (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Josep Samitier \nGroup lead ICMS: Jaap den Toonder\nMicrofluidic herringbone device with self-assembled antibody monolayer for CTC separation\n\n\n15.46\nFloor Ummels (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Giuseppe Battaglia \nGroup lead ICMS: Willem Mulder\nCrossing the blood-brain barrier\n\n\n15.54\nLisa Pomp (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: José Antonio Del Río and Karen Wells \nGroup lead ICMS: Vito Conte\nEstablishment of an in vitro blood-brain barrier model on transwells for transendothelial transport studies\n\n\n16.04\nStan van Wetten (ICMS→IBEC) \nPartnership between: \nGroup lead IBEC: Sílvia Pujals \nGroup lead ICMS: Arthur de Jong\nCorrelating Light and Electron Microscopy for PLGA-PEG nanoparticle charactization\n\n\n16.12\nLaura van de Koppel (ICMS→IBEC) \nPartnership between: \nGroup leads IBEC: Elisabeth Engel and Bárbara Blanco \nGroup lead ICMS: Patricia Dankers\nEngineering a 3D model of lymphoma using a hydrogel for precise screening of therapeutics\n\n\n16.20\nBreak \n\n\n\n16.35\nRoger Riera Brillas (IBEC & ICMS) \nRoger was a member of the  group of Lorenzo Albertazzi at IBEC and is now a member of the group of Lorenzo Albertazzi at ICMS\n Live-cell uPAINT imaging of receptors\n\n\n17.00\nClosing remarks
URL:https://ibecbarcelona.eu/event/icms-ibec-joint-online-symposium-2/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220318T100000
DTEND;TZID=Europe/Madrid:20220318T120000
DTSTAMP:20260404T164928
CREATED:20220503T134531Z
LAST-MODIFIED:20220503T134532Z
UID:93992-1647597600-1647604800@ibecbarcelona.eu
SUMMARY:PhD Complementary Skills Session: Alicia Calvo-Villamañán
DESCRIPTION:Making your science accessible with illustrations and humour\n\n\n\nAlicia Calvo-Villamañán\, CNB – CSIC. \n\n\n\nAs researchers we are accustomed to sharing our science mostly with people that have similar sets of skills to ours. But what happens when we have to share our science with people whose backgrounds are radically different to what we’re used to? In these cases\, we enter the domain of science communication and science outreach\, a radically different way of communicating science that requires equally radically different skills of communication. \n\n\n\nScientific illustration is a great way to make one’s science more accessible to the general public\, as it helps others visualise complex scientific concepts that would be totally foreign to them otherwise. Being able to convert what we do every day in the lab into approachable illustrations takes a bit of imagination\, a lot of trial and error\, and why not\, a bit of humour as well. \n\n\n\nFrom very simple stick figures to more complex illustrations\, from digital art to more classical media\, helping others visualise your work will help you keep your audience more engaged with your work\, as well as help them understand it better. \n\n\n\n\n\n\n\nAlicia a postdoc in the lab of Dr. Álvaro San Millán. Her current research focuses on the understanding of sucessful plasmid-bacteria associations in nosocomimal infections to try to prevent the further dissemination of antimicrobial resistance in hospitals. \n\n\n\nPast research topics have included the study of CRISPR-Cas systems and the development of synthetic biology tools to tackle the challenge of antimicrobial resistance. \n\n\n\n“I am a sleepy\, caffeinated molecular biologist by day and a hyper scientific illustrator by night. You can learn more about my science outreach and scientific illustration work in this website.” \n\n\n\nYou can check here her publications \n\n\n\nThis seminar will be held at Tower I\, 11th floor Baobab room\, there will be 30 avialable seats\, the free spots will be assigned on a first come first served basis.
URL:https://ibecbarcelona.eu/event/phd-complementary-skills-session-alicia-calvo-villamanan/
LOCATION:IBEC\, floor 11\, Tower i
CATEGORIES:IBEC Seminar
END:VEVENT
END:VCALENDAR